Expert Review of Anticancer Therapy

Individualizing therapy for oropharyngeal cancer patients
pp. 1181-1184(4)
Authors: Demiroz, Candan; Eisbruch, Avraham

Clinical and biological diversity of splenic marginal zone lymphoma
pp. 1185-1189(5)
Author: Matutes, Estella

News in brief
pp. 1191-1193(3)

Pemetrexed for the treatment of non-small-cell lung cancer
pp. 1195-1209(15)
Authors: Manegold, Christian; Schmid-Bindert, Gerald; Pilz, Lothar R

Clinical efficacy and safety of zoledronic acid in prostate and breast cancer
pp. 1211-1218(8)
Author: Doggrell, Sheila A

Personalizing cancer care: updates on head and neck cancer
pp. 1219-1222(4)
Authors: de Souza, Jonas A; Cohen, Ezra E

Personalizing therapy for metastatic breast cancer
pp. 1223-1226(4)
Authors: Morris, Patrick G; Hudis, Clifford A

Management of conjunctival melanoma
pp. 1227-1239(13)
Authors: Damato, Bertil; Coupland, Sarah E

Is there a role for complementary therapy in the management of leukemia?
pp. 1241-1249(9)
Authors: Wesa, Kathleen M; Cassileth, Barrie R

Molecular profiling of laryngeal cancer
pp. 1251-1260(10)
Authors: Mäkitie, Antti A; Monni, Outi

Clinicopathologic and molecular disease prognostication for papillary thyroid cancer
pp. 1261-1275(15)
Authors: Miccoli, Paolo; Miccoli, Mario; Antonelli, Alessandro; Minuto, Michele N

Managing malignancies of the external auditory canal
pp. 1277-1282(6)
Author: Gidley, Paul W

Role of nucleophosmin in acute myeloid leukemia
pp. 1283-1294(12)
Authors: Meani, Natalia; Alcalay, Myriam

Recent breakthroughs in the understanding and management of chronic eosinophilic leukemia
pp. 1295-1304(10)
Authors: Lierman, Els; Cools, Jan

Emerging therapies for B-cell non-Hodgkin lymphoma
pp. 1305-1316(12)
Author: Briones, Javier

Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses
pp. 1317-1332(16)
Authors: de Souza, Ana Paula; Bonorino, Cristina

Acknowledgements
pp. 1345-1345(1)

Corrigenda
pp. 1347-1347(1)

Erratum
pp. 1348-1348(1)